52 Biggest Movers From Yesterday
Gainers
Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.
Kinnate Biopharma Inc. Announces FDA Clearance Of Investigational Drug Application For KIN-3248
Kinnate Biopharma Inc. (NASDAQ:KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers,
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows.
Kinnate Biopharma Details 2-Part Phase 1 Trial Design For Lead RAF Kinase Inhibitor Program At AACR-NCI-EORTC Virtual International Conference
Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers,
Kinnate Biopharma Inc. To Present Trial Design For Its Lead RAF Kinase Inhibitor Program At The AACR-NCI-EORTC Virtual International Conference
Kinnate Biopharma Inc. (NASDAQ:KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers,
